Charline Sommer
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Regulation of T cell tissue residency and activation in human PCLS.
Journal: Respiratory research
Published: August 29, 2025
Activation of CD8⁺ T Cells in the Human Ex Vivo Lung Tumor Microenvironment Using Anti-CD3/CD28 and Nivolumab.
Journal: European journal of immunology
Published: May 09, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.
Journal: Frontiers in immunology
Published: March 28, 2025
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Revival of recombinant IL-2 therapy - approaches from the past until today.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Type 2 responses determine skin rash during recombinant interleukin-2 therapy.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 08, 2024
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.
Journal: Journal of immunotoxicology
Published: April 05, 2024
Interleukin-2-induced skin inflammation.
Journal: European journal of immunology
Published: May 30, 2023
Age-dependent inflammatory response is altered in an ex vivo model of bacterial pneumonia.
Journal: Respiratory research
Published: February 09, 2023
Competitive fitness of Pseudomonas aeruginosa isolates in human and murine precision-cut lung slices.
Journal: Frontiers in cellular and infection microbiology
Published: July 12, 2022
Last Updated: 09/26/2026